Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 3Phase 3 2Phase 1/2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Sarcoma 1

Conditions

Ewing's Sarcoma Family of Tumors 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 143pembrolizumab 127Nivolumab 116Carboplatin 99Dexamethasone 93Rituximab 91Paclitaxel 87Gemcitabine 85Lenalidomide 75Cytarabine 74Radiotherapy 73Cisplatin 70Bevacizumab 64Etoposide 62fludarabine phosphate 58fludarabine 56Ipilimumab 55Docetaxel 54Bortezomib 54Prednisone 49Doxorubicin 48Temozolomide 47Everolimus 46Erlotinib Hydrochloride 46Fluorouracil 44Azacitidine 44Capecitabine 43Calcium Dobesilate 43Filgrastim 42Melphalan 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Has results × figitumumab × Clear all
NCT00560235 2015-10-28

Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors

Pfizer

Phase 1/2 Completed
138 enrolled 15 charts
Sarcoma

Ewing's Sarcoma Family of Tumors

NCT00147537 2013-10-30

Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer

Pfizer

Phase 1/2 Completed
282 enrolled 25 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡